Global Peripheral Arterial Disease (PAD) Drugs Market Study 2016-2026, by Segment (Clopidogrel (Plavix), Prasugrel (Effient), … …), by Market (Hospitals, Clinics, … …), by Company (AstraZeneca Plc. (UK), Bayer HealthCare Pharmaceuticals (Germ
SKU ID :99ST-14636456 | Published Date: 25-Oct-2019 | No. of pages: 50Description
Summary
The global Peripheral Arterial Disease (PAD) Drugs market will reach Volume Million USD in 2019 and with a CAGR xx% between 2020-2026.
Clopidogrel (Plavix)
Prasugrel (Effient)
Ticagrelor (Brilinta)
Vorapaxar (Zontivity)
Others
Demand Coverage (Market Size & Forecast, Consumer Distribution):
Hospitals
Clinics
Others
AstraZeneca Plc. (UK)
Bayer HealthCare Pharmaceuticals (Germany)
Bristol-Myers Squibb Company (US)
Merck & Co., Inc. (US)
Proteon Therapeutics, Inc. (US)
Sanofi S.A. (France)
Symic Bio, Inc. (US)
TheraVasc Inc. (US)
North America
Europe
Asia-Pacific
South America
Middle East & Africa
The global Peripheral Arterial Disease (PAD) Drugs market will reach Volume Million USD in 2019 and with a CAGR xx% between 2020-2026.
Product Type Coverage (Market Size & Forecast, Major Company of Product Type etc.):
Clopidogrel (Plavix)
Prasugrel (Effient)
Ticagrelor (Brilinta)
Vorapaxar (Zontivity)
Others
Demand Coverage (Market Size & Forecast, Consumer Distribution):
Hospitals
Clinics
Others
Company Coverage (Sales data, Main Products & Services etc.):
AstraZeneca Plc. (UK)
Bayer HealthCare Pharmaceuticals (Germany)
Bristol-Myers Squibb Company (US)
Merck & Co., Inc. (US)
Proteon Therapeutics, Inc. (US)
Sanofi S.A. (France)
Symic Bio, Inc. (US)
TheraVasc Inc. (US)
Major Region
MarketNorth America
Europe
Asia-Pacific
South America
Middle East & Africa
TOC
Tables & Figures
Companies
- PRICE
-
$1800$3600Buy Now